Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Shared Decision Making Rarely Happens for Lung Cancer Screening-Reply.

Reuland DS, Malo TL, Brenner AT.

JAMA Intern Med. 2019 Jan 1;179(1):122-123. doi: 10.1001/jamainternmed.2018.6986. No abstract available.

PMID:
30615085
2.

A content analysis of HPV vaccination messages available online.

Calo WA, Gilkey MB, Malo TL, Robichaud M, Brewer NT.

Vaccine. 2018 Nov 26;36(49):7525-7529. doi: 10.1016/j.vaccine.2018.10.053. Epub 2018 Oct 23.

PMID:
30366803
3.

Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination.

Kasting ML, Christy SM, Sutton SK, Lake P, Malo TL, Roetzheim RG, Schechtman T, Zimet GD, Walkosz BJ, Salmon D, Kahn JA, Giuliano AR, Vadaparampil ST.

Prev Med. 2018 Nov;116:143-149. doi: 10.1016/j.ypmed.2018.09.004. Epub 2018 Sep 13.

4.

Evaluating Shared Decision Making for Lung Cancer Screening.

Brenner AT, Malo TL, Margolis M, Elston Lafata J, James S, Vu MB, Reuland DS.

JAMA Intern Med. 2018 Oct 1;178(10):1311-1316. doi: 10.1001/jamainternmed.2018.3054.

5.

Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation.

Malo TL, Hall ME, Brewer NT, Lathren CR, Gilkey MB.

Implement Sci. 2018 Apr 19;13(1):57. doi: 10.1186/s13012-018-0743-8.

6.

Human Papillomavirus Vaccination Training Experience Among Family Medicine Residents and Faculty.

Kasting ML, Scherr CL, Ali KN, Lake P, Malo TL, Johns T, Roetzheim RG, Quinn GP, Vadaparampil ST.

Fam Med. 2017 Oct;49(9):714-722.

7.

Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.

Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C.

Pediatrics. 2017 Jan;139(1). pii: e20161764. doi: 10.1542/peds.2016-1764. Epub 2016 Dec 5.

8.

Messages to Motivate Human Papillomavirus Vaccination: National Studies of Parents and Physicians.

Malo TL, Gilkey MB, Hall ME, Shah PD, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1383-1391.

9.

Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.

Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. Epub 2016 Aug 2.

10.

Provider-reported acceptance and use of the Centers for Disease Control and Prevention messages and materials to support HPV vaccine recommendation for adolescent males.

Scherr CL, Augusto B, Ali K, Malo TL, Vadaparampil ST.

Vaccine. 2016 Jul 29;34(35):4229-4234. doi: 10.1016/j.vaccine.2016.06.037. Epub 2016 Jun 20.

11.

Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.

Malo TL, Perkins RB, Lee JH, Vadaparampil ST.

Sex Transm Dis. 2016 Jul;43(7):438-44. doi: 10.1097/OLQ.0000000000000458.

12.

Quality of Physician Communication about HPV Vaccine-Response.

Gilkey MB, Malo TL, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):868. doi: 10.1158/1055-9965.EPI-16-0113. No abstract available.

13.

Quality of Physician Communication about HPV Vaccine-Response.

Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):866. doi: 10.1158/1055-9965.EPI-16-0046. Epub 2016 Feb 10. No abstract available.

14.

The content and context of physicians' communication with males about human papillomavirus vaccination.

Malo TL, Ali KN, Sutton SK, Perkins RB, Giuliano AR, Vadaparampil ST.

Hum Vaccin Immunother. 2016 Jun 2;12(6):1511-8. doi: 10.1080/21645515.2015.1132963. Epub 2016 Feb 2.

15.

Quality of physician communication about human papillomavirus vaccine: findings from a national survey.

Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1673-9. doi: 10.1158/1055-9965.EPI-15-0326. Epub 2015 Oct 22.

16.

Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.

Scherr CL, Lindor NM, Malo TL, Couch FJ, Vadaparampil ST.

Clin Genet. 2015 Dec;88(6):523-9. doi: 10.1111/cge.12563. Epub 2015 Feb 26.

17.

A preliminary investigation of genetic counselors' information needs when receiving a variant of uncertain significance result: a mixed methods study.

Scherr CL, Lindor NM, Malo TL, Couch FJ, Vadaparampil ST.

Genet Med. 2015 Sep;17(9):739-46. doi: 10.1038/gim.2014.185. Epub 2015 Jan 8.

18.

Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.

Malo TL, Giuliano AR, Kahn JA, Zimet GD, Lee JH, Zhao X, Vadaparampil ST.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2126-35. doi: 10.1158/1055-9965.EPI-14-0344. Epub 2014 Jul 15.

19.

Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.

Vadaparampil ST, Scherr CL, Cragun D, Malo TL, Pal T.

Clin Genet. 2015 May;87(5):473-7. doi: 10.1111/cge.12405. Epub 2014 May 9.

20.

From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors.

Vadaparampil ST, Malo TL, Nam KM, Nelson A, de la Cruz CZ, Quinn GP.

J Cancer Educ. 2014 Dec;29(4):709-19. doi: 10.1007/s13187-014-0643-9.

21.

Physicians' human papillomavirus vaccine recommendations, 2009 and 2011.

Vadaparampil ST, Malo TL, Kahn JA, Salmon DA, Lee JH, Quinn GP, Roetzheim RG, Bruder KL, Proveaux TM, Zhao X, Halsey NA, Giuliano AR.

Am J Prev Med. 2014 Jan;46(1):80-4. doi: 10.1016/j.amepre.2013.07.009.

22.

Human papillomavirus vaccine administration among Medicaid providers who consistently recommended vaccination.

Malo TL, Staras SA, Bynum SA, Giuliano AR, Shenkman EA, Vadaparampil ST.

Sex Transm Dis. 2014 Jan;41(1):24-8. doi: 10.1097/OLQ.0000000000000064.

23.

Factors associated With Medicaid providers' recommendation of the HPV vaccine to low-income adolescent girls.

Bynum SA, Staras SA, Malo TL, Giuliano AR, Shenkman E, Vadaparampil ST.

J Adolesc Health. 2014 Feb;54(2):190-6. doi: 10.1016/j.jadohealth.2013.08.006. Epub 2013 Sep 21.

24.

Qualitative responses to a national physician survey on HPV vaccination.

Vadaparampil ST, Murphy D, Rodriguez M, Malo TL, Quinn GP.

Vaccine. 2013 Apr 26;31(18):2267-72. doi: 10.1016/j.vaccine.2013.02.063. Epub 2013 Mar 13.

25.

Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.

Vadaparampil ST, Staras SA, Malo TL, Eddleton KZ, Christie J, Rodriguez M, Giuliano AR, Shenkman EA.

Cancer. 2013 Feb 1;119(3):621-8. doi: 10.1002/cncr.27735. Epub 2012 Aug 1.

26.

Physicians' intentions to change pap smear frequency following human papillomavirus vaccination.

Bruder KL, Downes KL, Malo TL, Giuliano AR, Salmon DA, Vadaparampil ST.

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):384-9. doi: 10.1016/j.jpag.2012.07.004. Epub 2012 Oct 22.

27.

Treatment Choices Based on OncotypeDx in the Breast Oncology Care Setting.

Malo TL, Lipkus I, Wilson T, Han HS, Acs G, Vadaparampil ST.

J Cancer Epidemiol. 2012;2012:941495. doi: 10.1155/2012/941495. Epub 2012 Aug 13.

28.

Do Florida Medicaid providers' barriers to HPV vaccination vary based on VFC program participation?

Malo TL, Hassani D, Staras SA, Shenkman EA, Giuliano AR, Vadaparampil ST.

Matern Child Health J. 2013 May;17(4):609-15. doi: 10.1007/s10995-012-1036-5.

29.

A national survey about human papillomavirus vaccination: what we didn't ask, but physicians wanted us to know.

Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST.

J Pediatr Adolesc Gynecol. 2012 Aug;25(4):254-8. doi: 10.1016/j.jpag.2012.02.007. Epub 2012 Apr 18.

30.

Physicians' undecided attitudes toward posthumous reproduction: fertility preservation in cancer patients with a poor prognosis.

Quinn GP, Knapp CA, Malo TL, McIntyre J, Jacobsen PB, Vadaparampil ST.

J Support Oncol. 2012 Jul-Aug;10(4):160-5. doi: 10.1016/j.suponc.2011.09.006. Epub 2012 Jan 23.

31.

Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.

Cragun D, Malo TL, Pal T, Shibata D, Vadaparampil ST.

Genet Test Mol Biomarkers. 2012 Jun;16(6):493-9. doi: 10.1089/gtmb.2011.0247. Epub 2012 Jan 6.

32.

A pilot study of knowledge and interest of genetic counseling and testing for hereditary breast and ovarian cancer syndrome among Puerto Rican women.

Vadaparampil ST, Quinn GP, Dutil J, Puig M, Malo TL, McIntyre J, Perales R, August EM, Closser Z.

J Community Genet. 2011 Dec;2(4):211-21. doi: 10.1007/s12687-011-0058-9. Epub 2011 Jul 12.

33.

Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.

Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X, Halsey N, Giuliano AR.

Vaccine. 2011 Nov 3;29(47):8634-41. doi: 10.1016/j.vaccine.2011.09.006. Epub 2011 Sep 14.

34.

HPV vaccine information-seeking behaviors among US physicians: government, media, or colleagues?

Bynum SA, Malo TL, Lee JH, Guiliano AR, Vadaparampil ST.

Vaccine. 2011 Jul 18;29(32):5090-3. doi: 10.1016/j.vaccine.2011.04.134. Epub 2011 May 25.

35.

Knowledge about hereditary colorectal cancer among colorectal cancer survivors.

Vadaparampil ST, Quinn G, Malo TL, Alvarez A, Miree CA, Shibata D.

Genet Test Mol Biomarkers. 2010 Oct;14(5):603-9. doi: 10.1089/gtmb.2010.0004. Epub 2010 Aug 19.

PMID:
20722496
36.

Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer.

Vadaparampil ST, Quinn GP, Knapp C, Malo TL, Friedman S.

Genet Med. 2009 Oct;11(10):757-65. doi: 10.1097/GIM.0b013e3181b3f451.

PMID:
19710615

Supplemental Content

Support Center